Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIP-CT hypertonic saline versus isotonic saline in preschool children with cystic fibrosis
NL-OMON46189Phase 3Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cystic fibrosis (CF) comparing Hypertonic saline with Isotonic saline control (2 arms). Primary endpoint: PRAGMA-CF structural airway disease score at 48 weeks. Started Oct 2016; status: active, not recruiting.
02
Drugs
hypertonic salineisotonic saline
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NL-OMON46189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46189.